TY - JOUR
T1 - Isolated late activation detected by magnetocardiography predicts future lethal ventricular arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy
AU - Kimura, Yoshitaka
AU - Takaki, Hiroshi
AU - Inoue, Yuko Y.
AU - Oguchi, Yasutaka
AU - Nagayama, Tomomi
AU - Nakashima, Takahiro
AU - Kawakami, Shoji
AU - Nagase, Satoshi
AU - Noda, Takashi
AU - Aiba, Takeshi
AU - Shimizu, Wataru
AU - Kamakura, Shiro
AU - Sugimachi, Masaru
AU - Yasuda, Satoshi
AU - Shimokawa, Hiroaki
AU - Kusano, Kengo
N1 - Publisher Copyright:
© 2017, Japanese Circulation Society. All rights reserved.
PY - 2018
Y1 - 2018
N2 - Background: Risk stratification of ventricular arrhythmias is vital to the optimal management in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). We hypothesized that 64-channel magnetocardiography (MCG) would be useful to detect isolated late activation (ILA) by overcoming the limitations of conventional noninvasive predictors of ventricular tachyarrhythmias, including epsilon waves, late potential (LP), and right ventricular ejection fraction (RVEF), in ARVC patients. Methods and Results: We evaluated ILA on MCG, defined as discrete activations re-emerging after the decay of main RV activation (%magnitude >5%), and conventional noninvasive predictors of ventricular tachyarrhythmias (epsilon waves, LP, and RVEF) in 40 patients with ARVC. ILA was noted in 24 (60%) patients. Most ILAs were found in RV lateral or inferior areas (17/24, 71%). We defined “delayed ILA” as ILA in which the conduction delay exceeded its median (50 ms). During a median follow-up of 42.5 months, major arrhythmic events (MAEs: 1 sudden cardiac death, 3 sustained ventricular tachycardias, and 4 appropriate implantable cardioverter defibrillator discharges) occurred more frequently in patients with delayed ILA (6/12) than in those without (2/28; log-rank: P=0.004). Cox regression analysis identified delayed ILA as the only independent predictor of MAEs (hazard ratio 7.63, 95% confidence interval 1.72–52.6, P=0.007), and other noninvasive parameters were not significant predictors. Conclusions: MCG is useful to identify ARVC patients at high risk of future lethal ventricular arrhythmias.
AB - Background: Risk stratification of ventricular arrhythmias is vital to the optimal management in patients with arrhythmogenic right ventricular cardiomyopathy (ARVC). We hypothesized that 64-channel magnetocardiography (MCG) would be useful to detect isolated late activation (ILA) by overcoming the limitations of conventional noninvasive predictors of ventricular tachyarrhythmias, including epsilon waves, late potential (LP), and right ventricular ejection fraction (RVEF), in ARVC patients. Methods and Results: We evaluated ILA on MCG, defined as discrete activations re-emerging after the decay of main RV activation (%magnitude >5%), and conventional noninvasive predictors of ventricular tachyarrhythmias (epsilon waves, LP, and RVEF) in 40 patients with ARVC. ILA was noted in 24 (60%) patients. Most ILAs were found in RV lateral or inferior areas (17/24, 71%). We defined “delayed ILA” as ILA in which the conduction delay exceeded its median (50 ms). During a median follow-up of 42.5 months, major arrhythmic events (MAEs: 1 sudden cardiac death, 3 sustained ventricular tachycardias, and 4 appropriate implantable cardioverter defibrillator discharges) occurred more frequently in patients with delayed ILA (6/12) than in those without (2/28; log-rank: P=0.004). Cox regression analysis identified delayed ILA as the only independent predictor of MAEs (hazard ratio 7.63, 95% confidence interval 1.72–52.6, P=0.007), and other noninvasive parameters were not significant predictors. Conclusions: MCG is useful to identify ARVC patients at high risk of future lethal ventricular arrhythmias.
KW - Epsilon waves
KW - Late potential
KW - Risk stratification
KW - Sudden cardiac death
KW - Ventricular tachycardia
UR - http://www.scopus.com/inward/record.url?scp=85039709553&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85039709553&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-17-0023
DO - 10.1253/circj.CJ-17-0023
M3 - Article
C2 - 28855434
AN - SCOPUS:85039709553
SN - 1346-9843
VL - 82
SP - 78
EP - 86
JO - Circulation Journal
JF - Circulation Journal
IS - 1
ER -